Zobrazeno 1 - 10
of 19
pro vyhledávání: '"LA Vallejo-Aparicio"'
Autor:
LA Vallejo-Aparicio, V Neches, B Hernández Novoa, G Casado, F Jodar, M Pinel, D Callejo-Velasco
Publikováno v:
Value in Health. 25:S129-S130
Autor:
S Moreno Guillén, A Rivero, P Ventayol, V Falcó, M Torralba, M Schroeder, V Neches, LA Vallejo-Aparicio, I Mackenzie, M Turner, C Harrison
Publikováno v:
Value in Health. 25:S122
Autor:
A Huerta, LA Vallejo-Aparicio
Publikováno v:
Value in Health. 20:A646
Autor:
García A; GSK, Tres Cantos, Spain. Electronic address: andrea.x.garcia@gsk.com., Vallejo-Aparicio LA; GSK, Tres Cantos, Spain., Begum N; Freelance C/O GSK, Wavre, Belgium., Nikitas G; GSK, Wavre. Belgium., González-Inchausti C; GSK, Tres Cantos, Spain., de Gomensoro E; GSK, Tres Cantos, Spain.
Publikováno v:
Vaccine [Vaccine] 2024 Sep 17; Vol. 42 (22), pp. 126155. Date of Electronic Publication: 2024 Aug 14.
Autor:
Pérez A; Management, Hospital Nuestra Señora De Sonsoles (Complejo Asistencial De Avila), Ávila, Spain., Fernández Prada M; Preventive Medicine and Public Health, Hospital Vital Alvarez Buylla, Asturias, Spain., Cassinello N; Financial and Accounting Management, Universidad Pontificia Comillas, Madrid, Spain., Vallejo-Aparicio LA; Market Access, GSK, Madrid, Spain., García A; Market Access, GSK, Madrid, Spain., González A; Health Economics and Market Access, Vivactis Weber, Madrid, Spain., Durán A; Health Economics and Market Access, Vivactis Weber, Madrid, Spain., Zozaya N; Health Economics and Market Access, Vivactis Weber, Madrid, Spain., Fernández I; Health Economics and Market Access, Vivactis Weber, Madrid, Spain., Daheron M; Health Economics and Market Access, Vivactis Weber, Madrid, Spain., Hidalgo Á; Weber Foundation, Madrid, Spain.; University of Castilla La Mancha, Toledo, Spain., Beck E; Value Evidence and Outcomes, GSK, Wavre, Belgium., García Ruiz A; IBIMA Platform Bionand, Universidad de Málaga - IBIMA Platform Bionand, Málaga, Spain.
Publikováno v:
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2024 Dec 31; Vol. 20 (1), pp. 2385175. Date of Electronic Publication: 2024 Aug 19.
Autor:
García A; Market Access, GSK, Madrid, Spain., Vallejo-Aparicio LA; Market Access, GSK, Madrid, Spain., Cambronero Martinez R; Market Access, GSK, Madrid, Spain.
Publikováno v:
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2024 Dec 31; Vol. 20 (1), pp. 2366353. Date of Electronic Publication: 2024 Jun 26.
Autor:
Moreno S; Hospital Ramón y Cajal, CIBERINFEC, Universidad de Alcalá, IRYCIS, Madrid, Spain., Rivero A; Hospital Reina Sofía, Córdoba, Spain., Ventayol P; Hospital Son Espases, Palma, Spain., Falcó V; Hospital Vall d'Hebron, Barcelona, Spain., Torralba M; Hospital de Guadalajara, Guadalajara, Spain., Schroeder M; ViiV Healthcare, Brentford, UK., Neches V; Market Access, GSK, P.T.M Severo Ochoa, 2-28760, Tres Cantos, Madrid, Spain. victoria.x.neches@gsk.com., Vallejo-Aparicio LA; Market Access, GSK, P.T.M Severo Ochoa, 2-28760, Tres Cantos, Madrid, Spain., Mackenzie I; HEOR Ltd, Cardiff, UK., Turner M; HEOR Ltd, Cardiff, UK., Harrison C; HEOR Ltd, Cardiff, UK.
Publikováno v:
Infectious diseases and therapy [Infect Dis Ther] 2023 Aug; Vol. 12 (8), pp. 2039-2055. Date of Electronic Publication: 2023 Jul 14.
Autor:
Martinón-Torres F; Translational Pediatrics and Infectious Diseases, Pediatrics Department, Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, Spain.; Genetics, Vaccines and Infections Research Group (GENVIP), Instituto de Investigación Sanitaria de Santiago, University of Santiago de Compostela, Santiago de Compostela, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain., de Miguel ÁG; Department of Preventive Medicine and Public Health, Universidad Rey Juan Carlos, Madrid, Spain., Ruiz-Contreras J; Department of Pediatrics, Hospital Universitario 12 de Octubre, Madrid, Spain.; Department of Pediatrics, Faculty of Medicine, Universidad Complutense de Madrid, Madrid, Spain., Vallejo-Aparicio LA; GSK, Madrid, Spain. laura.a.vallejo@gsk.com., García A; GSK, Madrid, Spain., Gonzalez-Inchausti MC; GSK, Madrid, Spain., de Gomensoro E; GSK, Madrid, Spain., Kocaata Z; GSK, Wavre, Belgium., Gabás-Rivera C; Outcomes'10, Castellón, Spain., Comellas M; Outcomes'10, Castellón, Spain., Prades M; Outcomes'10, Castellón, Spain., Lizán L; Outcomes'10, Castellón, Spain.; Department of Medicine, Universidad Jaime I, Castellón, Spain.
Publikováno v:
Infectious diseases and therapy [Infect Dis Ther] 2023 Jan; Vol. 12 (1), pp. 157-175. Date of Electronic Publication: 2022 Nov 11.
Autor:
Paly VF; ICON plc, Philadelphia, PA, USA., Vallejo-Aparicio LA; GSK, Madrid, Spain., Martin A; GSK, Brentford, UK., Izquierdo JL; Hospital Universitario de Guadalajara, Guadalajara, Spain., Riesco JA; Hospital San Pedro de Alcántara, Cáceres, Spain., Soler-Cataluña JJ; Hospital Arnau de Vilanova, Valencia, Spain., Abreu C; ICON Plc, New York, NY, USA., Biswas C; ICON Plc, Bengaluru, Karnataka, India., Ismaila AS; Value Evidence and Outcomes, GSK, Collegeville, PA, USA.; Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada.
Publikováno v:
International journal of chronic obstructive pulmonary disease [Int J Chron Obstruct Pulmon Dis] 2022 Dec 16; Vol. 17, pp. 3097-3109. Date of Electronic Publication: 2022 Dec 16 (Print Publication: 2022).
Autor:
Neches García V; Market Access, GlaxoSmithKline, Madrid, Spain., Vallejo-Aparicio LA; Market Access, GlaxoSmithKline, Madrid, Spain., Ismaila AS; Value Evidence and Outcomes, GlaxoSmithKline, Collegeville, PA, USA.; Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, ON, Canada., Sicras-Mainar A; Real Life Data, Atrys Health, Barcelona, Spain., Sicras-Navarro A; Real Life Data, Atrys Health, Barcelona, Spain., González C; Pneumology Unit, Hospital Clínico Universitario de Valencia, Valencia, Spain., Cuervo R; Medical Affairs, GlaxoSmithKline, Madrid, Spain., Shukla S; Value Evidence and Outcomes, GlaxoSmithKline, Collegeville, PA, USA., García-Peñuela M; Medical Affairs, GlaxoSmithKline, Madrid, Spain.
Publikováno v:
International journal of chronic obstructive pulmonary disease [Int J Chron Obstruct Pulmon Dis] 2022 Sep 07; Vol. 17, pp. 2161-2174. Date of Electronic Publication: 2022 Sep 07 (Print Publication: 2022).